5 completed. 5 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 1 | 3 | Completed 3 |
Follow Ascorbate: new trials by email Literature Review of Ascorbate trials Research Report on Ascorbate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas Ascorbate - Soft Tissue Sarcoma | Phase 1 / Phase 2 | Completed | Mohammed Milhem | 25 | 2019-06-27 | 2026-06-18 |
| A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) Gemcitabine, nab-paclitaxel, Pharmacological ascorbate - Pancreatic Neoplasms, Cancer of Pancreas | Phase 2 | Completed | University of Iowa | 40 | 2018-11-28 | 2026-07-23 |
| A Phase Ib Study Evaluating the Safety and Tolerability of Vitamin C in Patients With Intermediate or High Risk Myelodysplastic Syndrome With TET2 Mutations Vitamin C - Myelodysplastic Syndromes | Phase 1 / Phase 2 | Completed | NYU Langone Health | 4 | 2018-05-01 | 2024-03-27 |
| Pharmacological Ascorbate for Lung Cancer Paclitaxel, Carboplatin, Ascorbic Acid - Carcinoma, Non-Small-Cell Lung | Phase 2 | Completed | Joseph J. Cullen, MD, FACS | 55 | 2015-04-01 | 2024-08-20 |
| A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective Ascorbic Acid + Sorafenib, Sorafenib - Metastatic Hepatocellular Carcinoma, Advanced Liver Cancer | Phase 1 / Phase 2 | Completed | Thomas Jefferson University | 5 | 2012-09-01 | 2025-05-04 |
Adenocarcinoma (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Liver Neoplasms (1) · Myelodysplastic Syndromes (1) · Neoplasms (1) · Pancreatic Neoplasms (1) · Sarcoma (1)
Joseph J. Cullen, MD, FACS (1) · Mohammed Milhem (1) · NYU Langone Health (1) · Thomas Jefferson University (1) · University of Iowa (1)
United States (5)
Joseph J. Cullen, MD, FACS (2) · Daniel A Monti, MD, MBA (1) · Mohammad M Abdul Hay, MD (1) · Mohammed Milhem, MBBS (1)
PMID 28366679, PMID 35525024, PMID 39369582
P30CA086862 (2), P01CA217797 (1), U01CA140206 (1)